EFPIA MAPPs - newsletter  

masthead

E-NEWSLETTER
June 18th 2015
littlesq
Video
littlesq  
MAPPs: Saving Time, Saving Lives - Video

While progress is often slow and laborious when trying to gain traction for new ideas in the ‘Brussels Bubble’, there was much to be optimistic about in the Medicine’s Adaptive Pathways to Patients (MAPPs) meeting held on Thursday June 4 in Luxembourg. Organised as part of EFPIA’s general assembly, a broad cross section of stakeholders attended the MAPPs session to hear what had been accomplished over the last twelve months and discover how the initiative is being moved forward in partnership with the second Innovative Medicines Initiative (IMI2) and the European Medicine’s Agency (EMA).

See the video of the event: 

Play Video 2

Featuring:
  • Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency (EMA)
  • Karin Van Baelen, Head Global Regulatory Affairs at Janssen, J&J
  • Luk Maes, Executive Director Regulatory Europe, Bristol-Myers Squibb
  • James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline, UK
  • Sue Forda, VP-Global Regulatory Affairs - International, Eli Lilly
  • Nathalie Seigneuret, Senior Scientific Project Manager, Innovative Medicines Initiative
  • Jeremy Haigh, Chair, EFPIA MAPPs Task Force (moderator).


READ THE FULL EVENT REPORT...

 
Event Report and Presentations
littlesq  
evetnlittlesq Event Report and Presentations - MAPPs: Saving Time, Saving Lives

The full event report of the Medicine’s Adaptive Pathways to Patients (MAPPs) meeting held on Thursday June 4 in Luxembourg is available on the EFPIA MAPPs website. Presentations are also available for download.

READ THE FULL EVENT REPORT...

DOWNLOAD THE PRESENTATIONS...

 

 
Upcoming Event
littlesq  
BSBH-small 3

 
Better Science, Better Health: New Healthcare Models
Washington D.C. - October 27th - 28th 

There are multiple global initiatives currently investigating ways to improve and accelerate the way we bring needed new medicines to patients. How do we collaborate internationally to quantify uncertainty and harness real world evidence for better decision making and create better patient outcomes?

Featuring:  
  • Marc Berger, Vice President, Real World Data and Analytics, Pfizer
  • Magda Chlebus, Director Science Policy, EFPIA
  • Ruxandra Draghia-Akli, Director Health, DG Research and Innovation, European Commission
  • Hans-Georg Eichler, Senior Medical Officer, European Medicine’s Agency
  • Gigi Hirsch, Executive Director, MIT NewDig
  • Barbara Lopez Kunz, Global CEO, DIA
  • Irene Norstedt, Acting Executive Director, Innovative Medicine’s Initiative
  • Kenneth A. Oye, Associate Professor of Political Science and Engineering Systems, MIT
  • Gary A. Puckrein, President and CEO, National Minority Quality Forum
  • Mark Trusheim, Researcher, MIT Sloan School of Management

REQUEST YOUR INVITATION...

 
 
EFPIA Brussels Office
littlesq  
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: anna.szczepanska@efpia.eu or science-policy@efpia.eu 
littlesq

footer

littlesq

 




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Vital Transformation
107 Leopold III Laan
Wezembeek-Oppem, 1970
Belgium

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!